Position in ABBV
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$3,655,322
+$541,301 QoQ
Shares Held
14,526
+1.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.58%
of 13F equity value
Holder Rank
#1,514
of 4,150 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CNB Bank holds $13,085,387 across 11 Drug Manufacturers - General names. ABBV ranks #1 (27.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
14,526 | $3,655,322 | |
| 2 | MRK |
Merck & Co., Inc.
|
22,166 | $2,848,330 | |
| 3 | LLY |
ELI LILLY & Co
|
1,946 | $2,334,090 | |
| 4 | JNJ |
Johnson & Johnson
|
7,372 | $1,872,266 | |
| 5 | PFE |
Pfizer Inc
|
44,289 | $1,066,478 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
6,647 | $382,999 | |
| 7 | NVS |
Novartis AG
|
2,220 | $347,918 | |
| 8 | AMGN |
Amgen Inc
|
809 | $292,955 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,655,322 | 14,526 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $3,114,021 | 14,318 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $3,268,091 | 14,303 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $3,335,333 | 14,405 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $2,605,547 | 14,037 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $3,007,031 | 14,352 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $2,772,653 | 15,603 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $3,163,037 | 16,017 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $2,840,542 | 16,561 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $3,482,844 | 19,126 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $3,107,458 | 20,052 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $3,130,259 | 21,000 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $2,744,315 | 20,369 | Shares | Other | 2023-08-08 | |
| 2023-03-31 | $3,331,470 | 20,904 | Shares | Other | 2023-05-10 | |
| 2022-12-31 | $3,243,674 | 20,071 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $2,778,951 | 20,706 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $3,110,066 | 20,306 | Shares | Other | 2022-08-19 | |
| 2022-03-31 | $3,551,505 | 21,908 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $3,060,717 | 22,605 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $2,480,039 | 22,991 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $2,362,286 | 20,972 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $2,288,636 | 21,148 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $2,290,545 | 21,377 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $1,694,603 | 19,347 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $2,029,773 | 20,674 | Shares | Sole | 2020-07-14 | |
| 2020-03-31 | $1,466,581 | 19,249 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||